4//SEC Filing
Shanmugam Muthusamy 4
Accession 0001870913-25-000006
CIK 0001023024other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 4:32 PM ET
Size
8.5 KB
Accession
0001870913-25-000006
Insider Transaction Report
Form 4
Shanmugam Muthusamy
DirectorHEAD OF R&D, COO-NOVITIUM OPS
Transactions
- Sale
Common Stock
2025-08-15$87.15/sh−52,990$4,618,079→ 531,920 total(indirect: By LLC) - Sale
Common Stock
2025-08-14$89.48/sh−47,010$4,206,455→ 584,910 total(indirect: By LLC)
Holdings
- 5,000(indirect: By LLC)
Common Stock
- 92,588
Common Stock
Footnotes (4)
- [F1]The shares were sold in multiple trades at prices ranging from $88.20 to $90.11. The price reported above reflects the weighted average sales price.
- [F2]The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
- [F3]The shares were sold in multiple trades at prices ranging from $85.44 to $90.00. The price reported above reflects the weighted average sales price.
- [F4]The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001870913
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 4:32 PM ET
- Size
- 8.5 KB